Tasginga 150 Mg
Nilotinib 150 Mg Tasigna
Nilotinib, in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Brand name is Tasigna.
Nilotinib is a selective Bcr-Abl kinase inhibitor that is 10-30 fold more potent than imatinib in inhibiting Bcr-Abl tyrosine kinase activity and proliferation of Bcr-Abl expressing cells. Nolitinib was developed by Novartis and is sold under the trade name Tasigna.
Tasigna 150 Mg is available in form of capsules. Tasigna is manufactured by Novartis company. Tasgina 150 Mg is comes in 28 Capsules.
Guidance and Advice: Tasigna 150 Mg medicine is a prescription drug and should be used under proper medical guidance and advice. Do not share the Tasigna 150 Mg medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. If you have questions about the Tasigna 150 Mg drugs you are taking, check with your doctor / Medical adviser / Nurse / Hospital Institution / Health advisor or pharmacist.
Notice: The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.
Warning: Tasigna 150 Mg medicine out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.